Original Research
Accepted on 25 Feb 2026
Clinical efficacy of Comprehensive Traditional Chinese Medicine in Adjuvant Therapy for Stage Ib-IIIa Resected Non-Small Cell Lung Cancer: a multi-center, randomized, double-blind, placebo-controlled trial
in Pharmacology of Anti-Cancer Drugs